GLAXO logo

GlaxoSmithKline Pakistan Limited Stock Price

KASE:GLAXO Community·PK₨124.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 21 Fair Values set on narratives written by author

GLAXO Share Price Performance

PK₨390.50
-29.38 (-7.00%)
PK₨390.50
-29.38 (-7.00%)
Price PK₨390.50

GLAXO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

2 Risks
2 Rewards

GlaxoSmithKline Pakistan Limited Key Details

PK₨62.1b

Revenue

PK₨40.4b

Cost of Revenue

PK₨21.6b

Gross Profit

PK₨12.5b

Other Expenses

PK₨9.2b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
28.85
34.87%
14.80%
0%
View Full Analysis

About GLAXO

Founded
2001
Employees
1700
CEO
Erum Rahim
WebsiteView website
www.pk.gsk.com

GlaxoSmithKline Pakistan Limited operates as a biopharma company in Pakistan. It deals in anti-infective, dermatology, respiratory, immunology, oncology, infectious diseases, HIV, and vaccines therapy areas. The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol, and Cutivate brands. It also exports its products. The company was founded in 2001 and is headquartered in Karachi, Pakistan. GlaxoSmithKline Pakistan Limited is a subsidiary of GSK plc.

Recent GLAXO News & Updates

Recent updates

No updates

GlaxoSmithKline Pakistan Limited Competitors